Skip to main content

Table 3 Multivariable adjusted hazard ratio for each study outcome by gout status

From: Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

  Hazard Ratio (95% Confidence Interval)
  All study participants
Gout status No gout Treated gout Untreated gout
  N = 3,987 N = 129 N = 89
Mean sUA (SD) 6.06 (1.33) 7.18 (1.80) 7.00 (1.66)
All-cause death 1.00 0.84 (0.47, 1.50) 1.73a (1.03, 2.91)
CHD mortality 1.00 0.82 (0.43, 1.54) 2.00b (1.18, 3.36)
Coronary incidence 1.00 0.86 (0.58, 1.34) 1.67a (1.07, 2.62)
Stroke 1.00 2.11 (0.74, 6.03) 0.83 (0.11, 6.04)
  1. aP < 0.05 for comparison of untreated gout group to no gout group; bP < 0.01 for comparison of untreated gout group to no-gout group. The covariates adjusted for in this regression included: age, gender, blood pressure/hypertension, smoking, diabetes status, physical activity measure, hyperlipidemia, hypertriglyceridemia, renal function, and other non-steroidal anti-inflammatory drug use. Gout medications accounted for in this study were allopurinol, probenecid, and colchicine. CHD, coronary heart disease; sUA, serum urate.